CHRISTINA LAKE CANNABIS Net Assets
CHRISTINA LAKE CANNABIS net assets. Based on the latest financial reports, CHRISTINA LAKE CANNABIS (CLB) has net assets worth €9.25 Million EUR (≈ $10.82 Million USD) as of May 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€19.22 Million ≈ $22.47 Million USD) and total liabilities (€9.97 Million ≈ $11.65 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See CHRISTINA LAKE CANNABIS balance sheet quality to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €9.25 Million |
| % of Total Assets | 48.14% |
| Annual Growth Rate | -0.17% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 28.88 |
Net Assets of CHRISTINA LAKE CANNABIS (2021–2025)
Net assets of CHRISTINA LAKE CANNABIS from 2021 to 2025. This chart illustrates how CHRISTINA LAKE CANNABIS's net assets have evolved over time, based on quarterly financial data. Also explore CHRISTINA LAKE CANNABIS annual equity growth to track the company's year-over-year net asset growth rate.
Annual Net Assets for CHRISTINA LAKE CANNABIS (2021–2025)
The table below shows the annual net assets of CHRISTINA LAKE CANNABIS from 2021 to 2025. For live market cap and overall valuation, see market value of CHRISTINA LAKE CANNABIS.
| Year | Net Assets | Change |
|---|---|---|
| 2025-11-30 | €9.67 Million ≈ $11.31 Million |
-10.37% |
| 2024-11-30 | €10.79 Million ≈ $12.62 Million |
+44.67% |
| 2023-11-30 | €7.46 Million ≈ $8.72 Million |
-33.01% |
| 2022-11-30 | €11.14 Million ≈ $13.02 Million |
+14.36% |
| 2021-11-30 | €9.74 Million ≈ $11.39 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CHRISTINA LAKE CANNABIS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1119206300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
CHRISTINA LAKE CANNABIS Net Assets Breakdown (November 2025)
CHRISTINA LAKE CANNABIS net assets breakdown by equity component as of November 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €33.82 Million | 349.58% |
| Total Equity | €9.67 Million | 100.00% |
CHRISTINA LAKE CANNABIS Competitors by Market Cap
The table below lists competitors of CHRISTINA LAKE CANNABIS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tongaat
JSE:TON
|
$290.09K |
|
TTA Holdings Ltd
AU:TTA
|
$291.71K |
|
GCL Global Holdings Ltd Warrants
NASDAQ:GCLWW
|
$292.05K |
|
Itaconix plc
LSE:ITX
|
$292.08K |
|
Multistack International Ltd
AU:MSI
|
$289.33K |
|
Digital 9 Infrastructure PLC
LSE:DGI9
|
$288.72K |
|
Portmeirion Group PLC
LSE:PMP
|
$288.23K |
|
Blaize Holdings, Inc. Warrants
NASDAQ:BZAIW
|
$288.09K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CHRISTINA LAKE CANNABIS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,794,256 to 9,674,393, a change of -1,119,863 (-10.4%).
- Net loss of 2,991,316 reduced equity.
- Other factors increased equity by 1,871,453.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-2.99 Million | -30.92% |
| Other Changes | €1.87 Million | +19.34% |
| Total Change | €- | -10.37% |
Book Value vs Market Value Analysis
This analysis compares CHRISTINA LAKE CANNABIS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.03x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-11-30 | €0.08 | €0.00 | x |
| 2022-11-30 | €0.09 | €0.00 | x |
| 2023-11-30 | €0.06 | €0.00 | x |
| 2024-11-30 | €0.06 | €0.00 | x |
| 2025-11-30 | €0.04 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CHRISTINA LAKE CANNABIS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -30.92%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -22.37%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 2.10x
- Recent ROE (-30.92%) is above the historical average (-33.97%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -73.34% | -196.59% | 0.19x | 1.96x | €-8.12 Million |
| 2022 | -18.21% | -20.13% | 0.54x | 1.69x | €-3.14 Million |
| 2023 | -55.38% | -35.08% | 0.74x | 2.14x | €-4.88 Million |
| 2024 | 8.01% | 6.36% | 0.58x | 2.16x | €-214.43K |
| 2025 | -30.92% | -22.37% | 0.66x | 2.10x | €-3.96 Million |
Industry Comparison
This section compares CHRISTINA LAKE CANNABIS's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $7,839,663,408
- Average return on equity (ROE) among peers: -28.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CHRISTINA LAKE CANNABIS (CLB) | €9.25 Million | -73.34% | 1.08x | $290.05K |
| SHANG.FOS.PHARM.GR.H YC 1 (08HH) | $48.38 Billion | 9.77% | 0.93x | $1.19 Billion |
| PEPTONIC MEDICAL (28L) | $75.32 Million | -56.54% | 0.42x | $5.52 Million |
| Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) | $7.10 Billion | 30.01% | 0.65x | $692.11 Million |
| WEST ISLAND BRANDS INC. (39N0) | $3.27 Million | -157.21% | 0.88x | $1.34 Million |
| HANSOH PHARMAC. HD-00001 (3KY) | $22.65 Billion | 11.41% | 0.32x | $22.06 Billion |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $4.89 Million | -63.10% | 0.49x | $97.35K |
| CERENO SCIENTIFIC AB B (4A1) | $170.06 Million | -9.56% | 0.06x | $98.21 Million |
| MAPLE LEAF GREEN WORLD (4HV0) | $-11.72 Million | 0.00% | 0.00x | $504.30K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-815.79K | 0.00% | 0.00x | $134.78K |
| RED LIGHT HOLLAND CORP. (4YX) | $29.16 Million | -49.27% | 0.13x | $6.62 Million |
About CHRISTINA LAKE CANNABIS
Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It provides distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christ… Read more